NEW!

More documents

Recommendations

Info

Annual Meeting Programs by TopicContinued C162 Precision Neurology: Precision Directed Genetic Therapeutics C168 Clinical E-Pearls C170 Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease S38 General Neurology: Therapeutics . . . . . . . . . 110 C177 Therapy in Neurology III C180 Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I C186 Neurologic Case Studies in Pregnancy I C190 Therapy in Neurology IV C193 Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II C200 Neurologic Case Studies in Pregnancy II C204 Important Drug Interactions for Neurologists and Psychiatrists C206 Neuro Flash: MRI and Multiple Sclerosis C214 Neurology Update III C219 Neurologic Complications of Medical Disease: An Overview C225 Neurology Update IV C230 Neurologic Complications of Medical and Surgical Therapies Global Health S6 Global Health . . . . . . . . . . . . . . . . . 41 I8 Emerging Technologies for Neurological Research and Care: #Emerging-Tech #Neurologist @AAN . . . . . 85 I9 S Sleep, Clocks, and Alzheimer’s Disease . . . . . 104 C201 Neurocysticercosis and Globalization I14 Practical Approaches to Narrowing the Epilepsy Treatment Gap. . . . . . . . . . . . . . . . . 147 Headache C30 Chronic Migraine Education Program I I2 Stroke in the Elderly and Young: Challenges for the Next Decade . . . . . . . . . . . . . . . . . 40 C43 Chronic Migraine Education Program II C52 Case Studies: Challenging Headache Cases C59 S Interventional Treatment of Migraine and Other Headache Disorders I3 S New and Emerging Therapeutic Options in Migraine and Other Headache Disorders . . . . . . . . . . 58 I5 Sex-related Factors in Neurological Disease . . . . 61 I8 Emerging Technologies for Neurological Research and Care: #Emerging-Tech #Neurologist @AAN . . . . . 85 S26 Headache. . . . . . . . . . . . . . . . . . . 86 C128 Management of Migraine and Psychiatric Comorbidities C137 Introduction to Primary Headache Disorders I C152 Introduction to Primary Headache Disorders II C176 Therapy of Headache C221 Hot Topics in Headaches and Related Disorders I C232 Hot Topics in Headaches and Related Disorders II Infectious Disease C21 Neuro Flash: Approach to Acute CNS Infections C35 Differential Diagnosis of Neurologic Infections C65 Infections of the Nervous System I C76 Infections of the Nervous System II C89 Infections of the Nervous System III C175 The Interface Between Infection and Cerebrovascular Disease S53 Infectious Disease . . . . . . . . . . . . . . . 148 Movement Disorders C15 S Redefining Parkinson’s Disease: Challenging the Past and Preparing For the Future C17 Paroxysmal Movement Disorders C31 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment S5 Movement Disorders: Parkinson’s Disease and Atypical Parkinsonian Syndromes: Biomarkers. . . . 37 I1 S Redefining Parkinson’s Disease: Novel Approaches to Understanding Its Mechanisms and Developing Treatments . . . . . . . . . . . . . . . . . . 38 C53 Case Studies: Unusual Movement Disorders C66 Movement Disorders for the General Neurologist I C77 Movement Disorders for the General Neurologist II C90 Movement Disorders for the General Neurologist III S19 Movement Disorders: Parkinson’s Disease and Atypical Parkinsonian Syndromes: Phenomenology. . 66 C108 Nonmotor Manifestations of Parkinson’s Disease I C116 $ Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop (registration required) I7 The Human Connectome: Implications for Clinical Neurology. . . . . . . . . . . . . . . . . . . 84 I8 Emerging Technologies for Neurological Research and Care: #Emerging-Tech #Neurologist @AAN . . . . . 85 C122 Nonmotor Manifestations of Parkinson’s Disease II S25 Movement Disorders: Huntington’s Disease. . . . . 86 C132 Balance and Gait Disorders C135 Neuro Flash: Child Neurology 152 2016 AAN Annual Meeting Abstract Listing
$ A registration fee is required L The program is one of the AAN Leadership University sessions S The course is part of a Subspecialty in Focus track I The program is one of the I Talk sessions Learning Lab Excitement of Discovery Health & Wellness Real World of Neurology The program is part of the Experiential Learning Area sessions S27 Movement Disorders. Essential Tremor and Tardive Dyskinesia . . . . . . . . . . . . . . . . . . 90 C147 $ Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop (registration required) S30 Movement Disorders: Ataxias and Other Hyperkinetic Movement Disorders . . . . . . . . . . . . . . 102 C158 The Dystonias: Diagnosis, Treatment, and Update on Causes C173 Therapy of Movement Disorders: A Case-based Approach C188 $ Clinical Uses of Botulinum Toxin for Headache Skills Workshop (registration required) S40 Movement Disorders: Parkinson’s Disease Clinical Trials and Therapeutics . . . . . . . . . . . . . 124 C197 Approach to the Shaky Patient C205 Cerebellar and Afferent Ataxias: Diagnosis and Management C212 Overview of Parkinson’s Disease C215 Deep Brain Stimulation Management I C226 Deep Brain Stimulation Management II MS and CNS Inflammatory Disease C18 Multiple Sclerosis Overview: Basic and Translational Science S2 Multiple Sclerosis: Animal Models and In Vitro Studies 18 C32 Multiple Sclerosis Overview: Clinical Advances I C44 Multiple Sclerosis Overview: Clinical Advances II C54 Case Studies: Multiple Sclerosis C61 Morning Report: Multiple Sclerosis S12 Neuromyelitis Optica and Autoimmune Encephalities . 57 I5 Sex-related Factors in Neurological Disease . . . . 61 C85 Multiple Sclerosis Essentials C101 Controversies in Multiple Sclerosis Therapy C109 Pediatric MS: Diagnosis and Treatment I7 The Human Connectome: Implications for Clinical Neurology. . . . . . . . . . . . . . . . . . . 84 I8 Emerging Technologies for Neurological Research and Care: #Emerging-Tech #Neurologist @AAN . . . . . 85 S24 Clinical Outcomes and Treatment Strategies in Multiple Sclerosis . . . . . . . . . . . . . . . 86 S29 Pediatric Multiple Sclerosis . . . . . . . . . . . 90 C144 Multiple Sclerosis Therapy: Symptom Management I10 Remyelination and Repair in Multiple Sclerosis . . 106 S37 Risk Factors for Multiple Sclerosis. . . . . . . . . 110 C181 Multiple Sclerosis Therapy: Disease-modifying Treatment I S41 Advanced Neuroimaging in Multiple Sclerosis . . . . 124 C194 Multiple Sclerosis Therapy: Disease-modifying Treatment II C206 Neuro Flash: MRI and Multiple Sclerosis S45 MRI and OCT Outcomes in Multiple Sclerosis . . . . 132 C216 Neuromyelitis Optica Spectrum Disorders S49 Clinical Trials in Multiple Sclerosis I . . . . . . . . 144 S51 Clinical Trials in Multiple Sclerosis II . . . . . . . . 148 Neuro Trauma, Critical Care, and Sports Neurology C38 $ Sports Concussion Skills Workshop I (registration required) C49 $ Sports Concussion Skills Workshop II (registration required) C58 Case Studies in the ICU S11 Neuro Trauma and Sports Neurology . . . . . . . 44 C79 Emergency Neurology Topics: Status Epilepticus and Pediatric Neurology Emergencies C92 Emergency Neurology Topics: Acute/Subacute Weakness and Subarachnoid Hemorrhage C97 Severe TBI: From ICU to Rehabilitation S23 Section Topic Controversies: The Role of Rest vs. Active Intervention Following Concussion . . . . . . . . . . . . . . . . . . 80 C129 Neurologic Intensive Care I C138 Neurologic Intensive Care II C149 Sports Neurology: Non-concussion Overview I C153 Neurologic Intensive Care III C165 Sports Neurology: Non-concussion Overview II C166 S Acute Neurological Emergencies C179 Sports Concussion and Other Mild Concussive Injuries I I11 S Neurocritical Care and Neuroscience Crossroads: From Bench To Bedside . . . . . . . . . . . . . 126 C192 Sports Concussion and Other Mild Concussive Injuries II C211 Emergency Room Neuro-ophthalmology S46 Critical Care . . . . . . . . . . . . . . . . . . 132 C222 Critical Care EEG Monitoring I13 S Sports-related Concussion: Vision and Vestibular Insights. . . . . . . . . . . . . . . . . . . . 146 Neuroepidemiology I2 Stroke in the Elderly and Young: Challenges for the Next Decade . . . . . . . . . . . . . . . . . 40 S32 Neuroepidemiology . . . . . . . . . . . . . . . 102 I9 S Sleep, Clocks, and Alzheimer’s Disease . . . . . 104 Neuromuscular and Clinical Neurophysiology (EMG) C19 C33 C45 Peripheral Neuropathy I Peripheral Neuropathy II Peripheral Neuropathy III TOPIC LIST Fast and easy registration · AAN.com/view/AM16 153
Page 1 and 2:
NEW! Dates • Format • Value SCI
Page 3 and 4:
See the value! 2015 Meeting Price 2
Page 5 and 6:
What’s Inside Table of Contents I
Page 7 and 8:
Meeting! INTRODUCTION See You in Va
Page 9 and 10:
Additional Information INTRODUCTION
Page 11 and 12:
OVERVIEWS Mon April 18 Tue April 19
Page 13 and 14:
Schedule Planning Forms Use the con
Page 15 and 16:
My Friday $ A registration fee is r
Page 17 and 18:
Hot Topics Plenary Session Friday,
Page 19 and 20:
$ A registration fee is required L
Page 21 and 22:
Meeting Schedule 6:30 a.m.-8:30 a.m
Page 23 and 24:
Poster Session Schedule and Floorpl
Page 25 and 26:
Meeting Schedule P1.029 Efficacy an
Page 27 and 28:
Presenters Stand by Posters 5:30 p.
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
New Faculty and Trainee Reception!
Page 37 and 38:
Meeting Schedule 11:30 a.m.-6:30 p.
Page 39 and 40:
Saturday, April 16 1:00 p.m.-3:00 p
Page 41 and 42:
Meeting Schedule 1:00 p.m.-5:30 p.m
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Sunday, April 17 Scientific Platfor
Page 61 and 62:
Page 63 and 64:
I5 1:00 p.m.-5:30 p.m. Integrated N
Page 65 and 66:
Opening Party Experience New Ways t
Page 67 and 68:
Page 69 and 70:
Don’t Forget to Visit the Exhibit
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
P3.391 The Quix Test: A 30 Second T
Page 81 and 82:
Annual Meeting App Now Available Th
Page 83 and 84:
Meeting Schedule 9:00 a.m.-11:30 a.
Page 85 and 86:
Page 87 and 88:
I8 1:00 p.m.-5:30 p.m. Integrated N
Page 89 and 90:
Industry Therapeutic Updates Indust
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104: Frontiers in Neuroscience Plenary S
Page 105 and 106: Meeting Schedule 1:00 p.m.-3:00 p.m
Page 109 and 110: $ A registration fee is required L
Page 113 and 114: Meeting Schedule 6:30 a.m.-8:30 a.m
Page 115 and 116: Presenters Stand by Posters 5:30 p.
Page 125 and 126: Clinical Trials Plenary Session Wed
Page 131 and 132: Scientific Platform Sessions Meetin
Page 133 and 134: My Thursday $ A registration fee is
Page 135 and 136: Meeting Schedule 6:30 a.m.-8:30 a.m
Page 145 and 146: Neurology Year in Review Plenary Se
Page 149 and 150: 1:00 p.m.-5:30 p.m. Integrated Neur
Page 151 and 152: New Date and Time: CLOSING PARTY HA
Page 153: $ A registration fee is required L
Page 159 and 160: Association of Indian Neurologists
Page 161 and 162: Potamkin Prize for Research in Pick
Page 163 and 164: Cool An AAN initiative to help buil
Page 165 and 166: Closing Party Happy Hour Thursday,
Page 167 and 168: Annual Meeting Attendee Pricing: Go
Page 169 and 170: Disclaimers/Disclosures Disclaimer
Page 171 and 172: Hotel Reservations Why Book a Hotel
Page 173 and 174: Sitka Sq Abbott St Ontario St Ontar
Page 175 and 176: Luggage Restrictions for carry-on b
Page 177 and 178: 68 th Annual Meeting Exhibitors as
Page 179 and 180: 68 th Annual Meeting Planning Meeti
Page 181 and 182: Jonathan S. Katz, MD Jori Fleisher,
Page 183 and 184: AAN Leadership University courses a
show all

NEW!

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?